New Catheter Technique Saves Heart Patients From Surgery

Patients with failing mechanical heart valves finally have hope, thanks to a breakthrough procedure that replaces risky surgery with a minimally invasive catheter technique.

A team from Spain's National Cardiovascular Research Center and Hospital Clínico Universitario de Valladolid has successfully treated patients whose mechanical aortic valves stopped working properly. For decades, the only option for these patients was repeat open-heart surgery, a procedure so dangerous that many couldn't survive it.

Dr. Borja Ibáñez, who led the research published in European Heart Journal, faced patients with severely damaged valves and no good options. The surgical risk was too high, and no catheter-based alternatives existed for mechanical valves.

The new technique, called mechanical valve-in-valve (ViMech), works by carefully breaking apart and removing the failed valve's moving disks through a catheter. Special protection systems prevent any debris from entering the bloodstream. Then doctors insert a new valve through the same catheter, restoring normal blood flow.

The team spent months perfecting the approach in experimental models before treating their first patient. The careful preparation paid off when they successfully performed the procedure on three patients aged 67 to 79, all of whom had either undergone multiple heart surgeries or faced complications that made traditional reoperation impossible.

Dr. Ignacio J. Amat Santos, who performed the procedures, calls it a radical change in managing these complex cases. All three interventions were completed through the femoral artery in the leg, avoiding any chest incisions.

The results have been remarkable. All patients immediately regained normal valve function and recovered quickly. Six months later, every patient remains alive, symptom-free, and living normally with their new valves.

The Ripple Effect

The breakthrough extends beyond the operating room. Patients who received the new transcatheter valves no longer need lifelong blood thinners, unlike those with traditional mechanical valves. This dramatically improves safety and quality of life for fragile patients who often struggle with anticoagulation medication.

Dr. Alberto San Román notes that while the study involved only three patients, it represents the first complete journey from laboratory concept to successful human application. The work proves that percutaneous treatment of defective mechanical valves is not just possible but practical.

Mechanical heart valves have been the gold standard for younger patients because they last longer than biological valves. However, when they fail, patients often find themselves trapped with no safe treatment path. This new technique could change the outlook for thousands of patients worldwide.

The success of these first procedures opens doors for patients who previously lived with the constant fear of valve failure and inoperable complications.